William L. Isley, MD
Isley WL. Pioglitazone did not reduce a composite endpoint of macrovascular complications and increased risk for heart failure in type 2 diabetes with macrovascular disease. ACP J Club. 2006;144:34. doi: 10.7326/ACPJC-2006-144-2-034
Download citation file:
Published: ACP J Club 2006;144(2):34.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use